- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.04. | Roche's Columvi combo gains EC approval for DLBCL | ||
| 14.04. | Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial | ||
| 14.04. | Kyowa Kirin constructs drug manufacturing facility in Japan | ||
| 14.04. | Sandoz challenges Amgen's Enbrel patents in US antitrust lawsuit | ||
| 14.04. | BMS' Opdivo combo approved in US for hepatocellular carcinoma | ||
| 11.04. | Novartis commits $23bn to US manufacturing amid tariff threats | ||
| 11.04. | Pluri's immune cell expansion technologies gain patents | ||
| 11.04. | FDA to phase out animal testing with AI and lab-based models | ||
| 11.04. | AstraZeneca's oral breast cancer drug Truqap greenlit for NHS use | ||
| 11.04. | NMPA approves BBM and Takeda China's haemophilia B therapy | ||
| 11.04. | Can AI replace medical writers? Experts say not immediately | ||
| 11.04. | FDA approves Biocon Biologics' bevacizumab biosimilar for cancer | ||
| 10.04. | Keros Therapeutics considers sale amid investor pressure | ||
| 10.04. | Cingulate secures $3m to advance once-daily anxiety treatment | ||
| 10.04. | Tempest hits funding block for Phase III liver cancer drug-in-waiting | ||
| 10.04. | MHRA reconfirmed as WHO biologics partner amid US withdrawal | ||
| 10.04. | "Resign or be fired" - APHA executive director calls out RFK Jr | ||
| 10.04. | AAN 2025: Long-term outcome data on steroid regimens in MG may guide treatment standards | ||
| 10.04. | PharmaLogic to boost radiopharma offerings with Agilera acquisition | ||
| 10.04. | FDA approves injectable antibiotics for B Braun drug delivery system | ||
| 09.04. | Merida launches with $121m to target autoimmune antibodies | ||
| 09.04. | IRA holds the scope to shape pharma's research strategy, say experts | ||
| 09.04. | Beyond oncology: The expanding potential of cell and gene therapies | ||
| 09.04. | 60 Degrees and Yale to progress tafenoquin for babesiosis | ||
| 09.04. | Pharma CEOs warn EC President of "risk of exodus" to US |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
